Literature DB >> 8867614

Murine humoral immune response against recombinant structural proteins of hepatitis C virus distinct from those of patients.

M Ahmed1, T Shikata, M Esumi.   

Abstract

We examined the humoral immune response to recombinant structural proteins of hepatitis C virus (HCV) such as C, E1 and E2 in immunized mice. Mice showed high induction of antibodies against these three structural proteins. Conformational and/or linear epitopes of these regions showed high responses in mice. Comparison with patients revealed higher anti-E1 and anti-E2 responses in mice and 15 immunoreactive peptides which are unique to mice, especially 11 peptides from the E2 region. The hydrophilic regions of these proteins were found to be the most immunogenic. Therefore, the murine immune system against recombinant E1 and E2 glycoproteins was distinct from those of patients in natural infection, and may be a target to find protective activity against HCV infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8867614     DOI: 10.1111/j.1348-0421.1996.tb03321.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

1.  Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.

Authors:  F Bugli; N Mancini; C Y Kang; C Di Campli; A Grieco; A Manzin; A Gabrielli; A Gasbarrini; G Fadda; P E Varaldo; M Clementi; R Burioni
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype.

Authors:  Roberto Burioni; Yoshiharu Matsuura; Nicasio Mancini; Hideki Tani; Tatsuo Miyamura; Pietro E Varaldo; Massimo Clementi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Genetic and serological evidence for multiple instances of unrecognized transmission of hepatitis C virus in hemodialysis units.

Authors:  M Mizuno; T Higuchi; K Kanmatsuse; M Esumi
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.